Key facts
- Notable investors include Page One Ventures, Kicker Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Place Genomics
- ·The full record, as it builds
Funding rounds
No funding rounds for Place Genomics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Place Genomics
Developer of genomic analysis technology designed to provide detailed genetic inside for health research and personalised medicine. the company offers a range of laboutry and computation services including proximity ligation sequencing genomic mapping and advanced bioinformatics providing research , healthcare provider and biotech firms with precise callable and tools that facilitate the understanding of complex structures and support the development of targeted therapeutics and diagnostics
- Sector
- Healthcare
- HQ
- Pleasanton, CA, United States
- Founded
- 2024
- Website
- placegenomics.com/
- Ownership
- Privately Held (backing)
Place Genomics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Place Genomics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Place Genomics in its N-PORT filings yet. We sweep new filings monthly.